The clinical syndrome of SIR, defined by elevated circulating white blood cell- and thrombocyte counts and acute-phase proteins such as C-reactive protein [35], has been consistently observed to confer poor outcome [36], as shown valid in all stages of CRC [8, 9]. This evidence concerns the gene CRP and colorectal carcinoma.